Application of High Sensitivity Troponin in Suspected Myocardial Infraction
Application of High Sensitivity Troponin in Suspected Myocardial Infraction
Application of High Sensitivity Troponin in Suspected Myocardial Infraction
SENSITIVITY TROPONIN IN
SUSPECTED MYOCARDIAL
INFRACTION
Liron Naftali Ben Haim
Troponin
■ Crossbridge
■ Subuits: TnT, TnC, TnI
BIOMARKER
S
Study Questions
■ How can high-sensitivity troponin (hs-Tn) concentrations, its change during serial
sampling, and the time between sample be incorporated as a strategy to rule out
myocardial infarction (MI) in patients presenting to the emergency department with
chest pain?
■ The prognosis of patients with persistently elevated troponin who do not have MI
remains unclear.
Methods- acute study population
■ Troponin measurements
■ Serial resampling:
– Early resampling (>45 to 120 minutes)
– Late resampling (>120 to 210 minutes)
Methods- follow up
■ 23,327 patients.
■ 676 patients were excluded- STEMI
■ 22,651 patients
■ 9,604 patients- derivation data set; 13,047 validation data set.
■ Final diagnosis of MI in 3,455 patients (15.3%)
Results
Results
Results- Low risk
■ http://compass-mi.com/
■ Allows classification of patients into low risk and high risk categories.
Methods- long term risk assessments
■ Comparison of:
– Patients in the acute study population who did not have MI
– Persons in the general population
11 cohorts, 8 countries
Only troponin I was measured in the general population.
■ Detailed matching
■ End point- the incidence of MI or death from any cause in general population at 1 and 2
years.
Results- acute population without MI
■ 7,682 matched pairs.
Results- acute population without MI
■ The approach presented here provides risk probabilities for MI using a wide range of
cutoff combinations of troponin concentrations.
■ Assignment of patients to the low risk category may allow discharge after other life-
threatening causes of chest pain have been ruled out.
■ Patients assigned to the high risk category are candidates for early invasive strategies.
■ Patients with persistently high but nondynamic concentrations of troponin without MI-
troponin is a risk prediction biomarker.
Limitations